Effect of the DNA topoisomerase II inhibitor VP-16 on illegitimate recombination in yeast chromosomes

By Asami Y.   Jia D.-W.   Tatebayashi K.   Yamagata K.   Tanokura M.   Ikeda H.  

Gene, Vol. 291, Iss. 1, 2002-05 ,pp. : 251-257

Elsevier

Access to resources Recommend Favorite

Evaluation of the progeny of rats treated with topoisomerase II inhibitor vepesid

By Borovskaya T.   Gol'dberg V.   Shchemerova Yu.   Perova A.   Timina E.   Pakhomova A.  

Bulletin of Experimental Biology and Medicine, Vol. 141, Iss. 5, 2006-05 ,pp. : 578-580

Springer Publishing Company

Access to resources Recommend Favorite

Changes in Nuclear Protein Kinase C- Holoenzyme, Its Catalytic Fragments, and Its Activity in Polyomavirus-Transformed pyF111 Rat Fibroblasts while Proliferating and Following Exposure to Apoptogenic Topoisomerase-II Inhibitors

By Dal Pra I.   Whitfield J.F.   Chiarini A.   Armato U.  

Experimental Cell Research, Vol. 249, Iss. 1, 1999-05 ,pp. : 147-160

Elsevier

Access to resources Recommend Favorite

Human Topoisomerase II and II Interact with the C-Terminal Region of p53

By Cowell I.G.   Okorokov A.L.   Cutts S.A.   Padget K.   Bell M.   Milner J.   Austin C.A.  

Experimental Cell Research, Vol. 255, Iss. 1, 2000-02 ,pp. : 86-94

Elsevier

Access to resources Recommend Favorite

Development of optimal medium for production of commercially important monoclonal antibody 520C9 by hybridoma cell

By Sen Sucharita  

Cytotechnology, Vol. 65, Iss. 2, 2013-03 ,pp. : 233-252

Springer Publishing Company

Access to resources Recommend Favorite